Poster De Conférence Année : 2025

Unveiling Pathological Insights and Accelerating Antiviral Drug Discovery in Respiratory Viral Infections with Polarized Organoids

Résumé

Over the past decade, organoid models have not only emerged as an innovative research model but also as a valuable tool in precision medicine, particularly in the field of respiratory diseases. These three-dimensional in vitro models can replicate the complex architecture of human tissues, providing opportunities to predict drug response. This is especially critical in the context of respiratory viruses for which effective antiviral treatments are often lacking. Moreover, respiratory organoids generated from individual human primary cells could revolutionize our understanding of pulmonary diseases like asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis (CF). This work aims to explore the role of respiratory organoids in precision medicine, focusing on their application in studying viral respiratory infection and their potential to personalize treatment approaches for patients.

Fichier principal
Vignette du fichier
P2M2025_Poster_organoids_20250307.pdf (1.24 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Licence

Dates et versions

hal-05065776 , version 1 (13-05-2025)

Licence

Identifiants

  • HAL Id : hal-05065776 , version 1

Citer

Elodie Alessandri-Gradt, Mathieu Hubert, Flora Archambault, Fabienne Tombette, Yves Cambet, et al.. Unveiling Pathological Insights and Accelerating Antiviral Drug Discovery in Respiratory Viral Infections with Polarized Organoids. THE THIRD P2M ROUEN INTERNATIONAL SYMPOSIUM -Pathways to PRECISION MEDECINE, Apr 2025, Rouen, France. ⟨hal-05065776⟩
153 Consultations
50 Téléchargements

Partager

  • More